The Latest in Alzheimer's & Cognition

Internal Medicine News

Pimavanserin found modestly effective in phase 2 Alzheimer’s psychosis study

November 14, 2017

Internal Medicine News

Unblinded data show extent of verubecestat’s failure in mild-moderate Alzheimer’s

November 12, 2017

Internal Medicine News

Amyloid imaging changed management for 80% of patients with uncertain dementia diagnosis

November 9, 2017

Internal Medicine News

New BACE1 study launches in the shadow of verubecestat’s demise

November 4, 2017

Internal Medicine News

Aducanumab continues to rack up positive numbers in phase 1b open-label extension

November 3, 2017

Internal Medicine News

Analysis of failed Alzheimer’s trials gives two antiamyloid antibodies new momentum

November 2, 2017

Internal Medicine News

AF patients without oral anticoagulation face higher dementia risk

October 26, 2017

Internal Medicine News

VIDEO: Alzheimer’s blood test expected soon

October 19, 2017

Internal Medicine News

Post-Ebola syndrome includes neurologic sequelae

October 15, 2017

Internal Medicine News

APOE affects tau pathology independent of amyloid-beta

October 4, 2017

Internal Medicine News

Personality changes may not occur before Alzheimer’s onset

September 29, 2017

Internal Medicine News

Higher BP targets suggested for elderly, cognitively impaired

September 27, 2017

Internal Medicine News

Study linked H2 receptor antagonists, but not PPIs, to dementia

September 5, 2017

Internal Medicine News

Fueling the Alzheimer’s brain with fat

August 23, 2017

Internal Medicine News

Cognitive decline not seen with lower BP treatment targets

August 21, 2017